{"id":"https://openalex.org/W90118834","doi":null,"title":"Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells.","display_name":"Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells.","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W90118834","mag":"90118834","pmid":"https://pubmed.ncbi.nlm.nih.gov/12202538"},"language":"en","primary_location":{"id":"pmid:12202538","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12202538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113396482","display_name":"Philip L. Penfold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Philip L Penfold","raw_affiliation_strings":["Save Sight Institute and Department of Clinical Ophthalmology, University of Sydney, New South Wales, Australia. ppenfold@eye.usyd.edu.au"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Save Sight Institute and Department of Clinical Ophthalmology, University of Sydney, New South Wales, Australia. ppenfold@eye.usyd.edu.au","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103652226","display_name":"Li Wen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070288036","display_name":"Michele C. Madigan","orcid":"https://orcid.org/0000-0003-1053-6979","observed_orcids":["https://orcid.org/0000-0003-1053-6979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele C Madigan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021189214","display_name":"Nicholas J. C. King","orcid":"https://orcid.org/0000-0002-3877-9772","observed_orcids":["https://orcid.org/0000-0002-3877-9772"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas J C King","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090224250","display_name":"Jan M. Provis","orcid":"https://orcid.org/0000-0002-6405-2868","observed_orcids":["https://orcid.org/0000-0002-6405-2868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan M Provis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.0523,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.97426493,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"43","issue":"9","first_page":"3125","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.13819999992847443,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.0340999998152256,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/choroidal-endothelial-cells","display_name":"choroidal endothelial cells","score":0.8930000066757202},{"id":"https://openalex.org/keywords/triamcinolone-acetonide","display_name":"triamcinolone acetonide","score":0.9710000157356262},{"id":"https://openalex.org/keywords/exudative-retinopathy","display_name":"exudative retinopathy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.8939999938011169},{"id":"https://openalex.org/keywords/endothelial-permeability","display_name":"endothelial permeability","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.8420000076293945},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.9729999899864197},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":1.0},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.8859999775886536},{"id":"https://openalex.org/keywords/mhc-class-ii","display_name":"MHC class II","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9639999866485596},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C16224149","wikidata":"https://www.wikidata.org/wiki/Q187637","display_name":"Cell adhesion molecule","level":2,"score":0.6449862718582153},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5760101079940796},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5216848850250244},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49395400285720825},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4338868260383606},{"id":"https://openalex.org/C2909375385","wikidata":"https://www.wikidata.org/wiki/Q187637","display_name":"Intercellular Adhesion Molecule-1","level":3,"score":0.42068466544151306},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3699495196342468},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.34978193044662476},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3269338011741638},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2836686372756958}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002829","descriptor_name":"Choroid","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D004553","descriptor_name":"Electric Conductivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018799","descriptor_name":"Intercellular Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019084","descriptor_name":"Fluorescent Antibody Technique, Indirect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12202538","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12202538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},{"id":"mag:90118834","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12202538","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W58932037","https://openalex.org/W104389636","https://openalex.org/W113737080","https://openalex.org/W127777169","https://openalex.org/W1479820498","https://openalex.org/W1593821986","https://openalex.org/W1964499056","https://openalex.org/W1977790296","https://openalex.org/W1982120546","https://openalex.org/W1984050208","https://openalex.org/W1984790768","https://openalex.org/W1988476950","https://openalex.org/W2003822242","https://openalex.org/W2004558662","https://openalex.org/W2009158237","https://openalex.org/W2010973417","https://openalex.org/W2012868183","https://openalex.org/W2021888919","https://openalex.org/W2034593795","https://openalex.org/W2035842239","https://openalex.org/W2056989349","https://openalex.org/W2060114316","https://openalex.org/W2077302000","https://openalex.org/W2079756593","https://openalex.org/W2092816889","https://openalex.org/W2129949645","https://openalex.org/W2135333970","https://openalex.org/W2154462339","https://openalex.org/W2154851868","https://openalex.org/W2166108068","https://openalex.org/W2196635150","https://openalex.org/W2473890466","https://openalex.org/W2522487239","https://openalex.org/W3202352366"],"related_works":["https://openalex.org/W2080358439","https://openalex.org/W2646355783","https://openalex.org/W101316802","https://openalex.org/W2000844441","https://openalex.org/W2889433606","https://openalex.org/W2026266301","https://openalex.org/W2027552966","https://openalex.org/W2078447772","https://openalex.org/W2385459201","https://openalex.org/W1218259679"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,23,111],"therapeutic":[2,253],"potential":[3,219,250],"of":[4,12,25,31,44,56,94,113,121,140,147,160,171,189,198,243,257],"TA,":[5],"an":[6,32],"anti-inflammatory":[7,224],"glucocorticoid,":[8],"for":[9,92,255],"the":[10,42,51,54,228,234],"treatment":[11,195,256],"exudative":[13,258],"retinopathy":[14],"has":[15,36,233],"been":[16,37],"examined":[17],"in":[18,39,67,126,208,246],"several":[19],"independent":[20],"clinical":[21],"studies.":[22],"modulation":[24],"permeability":[26,62,120,188,197,242],"and":[27,46,59,63,83,90,104,109,116,135,142,156,174,217,223,241],"adhesion":[28,64,96,101,238],"molecule":[29,65,97,102,239],"expression":[30,66,93,139,159,170,240],"epithelial":[33],"cell":[34,100,128],"line":[35],"described":[38],"vitro,":[40,247],"with":[41,80,153,167],"use":[43],"cytokines":[45,58],"triamcinolone":[47],"acetonide":[48],"(TA).":[49],"In":[50,226],"current":[52],"study,":[53],"influence":[55],"proinflammatory":[57],"TA":[60,84,117,194,232],"on":[61,118,144],"human":[68],"choroidal":[69,213,244],"endothelial":[70],"cells":[71],"(CECs)":[72],"was":[73,149,162,179],"investigated.":[74],"METHODS:":[75],"Human":[76,202],"CEC":[77,122,190,199,203],"isolates":[78,204],"treated":[79],"IFNgamma,":[81,114],"TNFalpha,":[82,115,157],"were":[85,124],"evaluated":[86],"by":[87,165,177,182],"flow":[88],"cytometry":[89],"immunocytochemistry":[91],"intercellular":[95],"(ICAM)-1,":[98],"vascular":[99],"(VCAM)-1,":[103],"major":[105],"histocompatibility":[106],"complex":[107],"(MHC)-I":[108],"-II.":[110],"effects":[112],"paracellular":[119],"monolayers":[123],"assessed":[125],"transendothelial":[127],"resistance":[129],"(TER)":[130],"assays.":[131],"RESULTS:":[132],"Both":[133],"IFNgamma":[134,155,184],"TNFalpha":[136],"significantly":[137,180],"upregulated":[138],"ICAM1":[141],"MHC-I":[143],"CECs.":[145],"Expression":[146],"VCAM1":[148],"induced":[150,163],"after":[151],"stimulation":[152,166,185],"both":[154],"whereas":[158,192],"MHC-II":[161,175],"only":[164],"IFNgamma.":[168],"Cytokine-induced":[169],"ICAM1,":[172],"MHC-I,":[173],"antigen":[176],"CECs":[178],"downregulated":[181],"TA.":[183],"also":[186],"increased":[187],"monolayers,":[191],"subsequent":[193],"decreased":[196],"monolayers.":[200],"CONCLUSIONS:":[201],"provide":[205],"a":[206,252],"useful":[207],"vitro":[209],"model":[210],"to":[211,221,236],"study":[212],"neovascular":[214],"membrane":[215],"characteristics":[216],"their":[218],"response":[220],"pro-":[222],"agents.":[225],"addition,":[227],"results":[229],"indicate":[230],"that":[231],"capacity":[235],"reduce":[237],"vessels":[245],"confirming":[248],"its":[249],"as":[251],"agent":[254],"macular":[259],"degeneration.":[260]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}